Say HELLO
To the FUTURE
Of your HEALTH

BioViva is committed to lengthening healthy human
lifespans with AAV and CMV gene therapy

BioViva will be with you
every step of the way

Heart disease, dementia, diabetes, and frailty…what do these all have in common?Aging. These chronic ailments are all complex disorders that are driven by cellular aging. Aging- associated diseases are the biggest cause of mortality on the planet.
BioViva is building a future for patients. Our AAV gene therapy is based on proven technology and our CMV gene therapy platform supports larger genetic payloads that are needed to treat complex diseases, minimizing the number of treatments patients will need.

Learn More

THE BIOVIVA PLATFORM

Our gene therapy development platform assists in the development of new therapeutics designed to help patient's cells behave more youthfully and ward off the degeneration of aging itself .
Our CMV gene therapy platform supports larger genetic payloads, minimizing the number of treatments patients will need.

Learn More

THE SCIENCE OF AGING

Your age is your biggest risk factor for disease. Cellular aging is the largest unmet medical need in the world, responsible 63% of death, globally. Right now 15% of Americans are 65 or older. That number is expected to balloon to over 20% by 2050.
From Alzheimer's to cancer, Chronic....

Learn More

JOIN OUR GENE DATABASE FOR FREE

CodeKeeper™ is BioViva's open access database for gene therapy. It is designed for anyone interested in what is happening in the gene therapy space. Advanced tools are available for universities, companies, independent researchers, and anyone else who is interested in understanding or contributing to the state-of-the-art. Our commitment to open access, open source, and open standards are powerful ideas that have, over the past three decades, repeatedly proven themselves. An increasing number of businesses and organizations are leveraging them to deliver evergreen services.

Learn More